Showing results (181-190 of 192) with videos related to
Sort By:
Pageof 20
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 25, 2000
Inhibition of monocyte chemotactic protein-1 synthesis by statinsM Romano, L Diomede, M Sironi, et al.Journal of Molecular Biology|July 25, 2000
Tetracycline affects abnormal properties of synthetic PrP peptides and PrP(Sc) in vitroF Tagliavini, G Forloni, L Colombo, et al.The Biochemical Journal|August 5, 1999
Molecular determinants of the physicochemical properties of a critical prion protein region comprising residues 106-126M Salmona, P Malesani, L De Gioia, et al.Nanotechnology|July 31, 2014
A biodistribution study of PEGylated PCL-based nanoparticles in C57BL/6 mice bearing B16/F10 melanomaM Lupi, C Colombo, R Frapolli, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 13, 2016
First next-generation sequencing full-genome characterization of a hepatitis C virus genotype 7 divergent subtypeM Salmona, A Caporossi, P Simmonds, et al.The Journal of Biological Chemistry|January 31, 1998
Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P componentB Bottazzi, V Vouret-Craviari, A Bastone, et al.Nature|December 10, 1999
CtBP/BARS induces fission of Golgi membranes by acylating lysophosphatidic acidR Weigert, M G Silletta, S Spanò, et al.The Journal of Biological Chemistry|November 23, 2000
A 7-kDa prion protein (PrP) fragment, an integral component of the PrP region required for infectivity, is the major amyloid protein in Gerstmann-Sträussler-Scheinker disease A117VF Tagliavini, P M Lievens, C Tranchant, et al.The American Journal of Pathology|January 1, 1996
beta PP and Tau interaction. A possible link between amyloid and neurofibrillary tangles in Alzheimer's diseaseG Giaccone, B Pedrotti, A Migheli, et al.Journal of Virology|July 15, 2003
Evaluation of quinacrine treatment for prion diseasesA Barret, F Tagliavini, G Forloni, et al.Pageof 20